THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Wei-Qun Ding to Neoplasms

This is a "connection" page, showing publications Wei-Qun Ding has written about Neoplasms.
Connection Strength

1.883
  1. Extracellular Vesicles in the Development of Cancer Therapeutics. Int J Mol Sci. 2020 Aug 24; 21(17).
    View in: PubMed
    Score: 0.379
  2. SRSF1 regulates exosome microRNA enrichment in human cancer cells. Cell Commun Signal. 2020 08 20; 18(1):130.
    View in: PubMed
    Score: 0.379
  3. The origin of exosomal miR-1246 in human cancer cells. RNA Biol. 2019 06; 16(6):770-784.
    View in: PubMed
    Score: 0.344
  4. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci. 2013 Jul 09; 14(7):14240-69.
    View in: PubMed
    Score: 0.231
  5. Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline). Cancer Lett. 2011 Dec 15; 312(1):11-7.
    View in: PubMed
    Score: 0.201
  6. Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Mol Cancer Ther. 2007 Apr; 6(4):1467-74.
    View in: PubMed
    Score: 0.150
  7. Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol Cancer Ther. 2006 Jul; 5(7):1864-72.
    View in: PubMed
    Score: 0.142
  8. N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death. Cancer Lett. 2010 Dec 08; 298(2):186-94.
    View in: PubMed
    Score: 0.047
  9. A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood. 2006 Feb 01; 107(3):980-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES